Cognitive Effects and Depression Associated With Taxane-Based Chemotherapy in Breast Cancer Survivors: A Meta-Analysis
Ibrahim EY, Domenicano I, Nyhan K, Elfil M, Mougalian SS, Cartmel B, Ehrlich BE. Cognitive Effects and Depression Associated With Taxane-Based Chemotherapy in Breast Cancer Survivors: A Meta-Analysis. Frontiers In Oncology 2021, 11: 642382. PMID: 33996556, PMCID: PMC8121254, DOI: 10.3389/fonc.2021.642382.Peer-Reviewed Original ResearchTaxane-based chemotherapyBreast cancerCognitive impairmentCognitive impairment 6 monthsChemotherapy-induced cognitive impairmentMonths of treatmentBreast cancer survivorsEffect sizeFunction domainNewcastle-Ottawa ScaleRisk of biasCourse of treatmentDifferent risk factorsMotor function domainsChemotherapy-induced impairmentsTreatment cessationCancer survivorsDepression AssociatedRisk factorsCognitive domainsOutcome studiesDatabases MEDLINEChemotherapyPRISMA statementMeta-Analysis